3Suppliers
2Customers
3Debt Items
20Related Chains

Source-Backed Evidence Depth

Castle Biosciences, Inc. (CSTL) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

9Total relationships
3Distinct source URLs
8High confidence
0.863Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Castle Biosciences, Inc. Suppliers

TickerNameConfidenceEvidence
SCIBASE SCIBASE 90% SciBase is entitled to royalties on our product sales, a mark-up on product sales to us, and a milestone payment upon achieving specified sales thresholds.
NORIDIAN-HEALTHCARE-SOLUTIONS-LLC NORIDIAN-HEALTHCARE-SOLUTIONS-LLC 80% The MAC responsible for administering claims for laboratory services located in Arizona is Noridian Healthcare Solutions, LLC ("Noridian").
MYGN Myriad Genetics, Inc. 72% Reciprocal relationship from MYGN graph: Reciprocal relationship from CSTL graph: Reciprocal relationship from MYGN graph: Reciprocal relationship from CSTL graph: Reciprocal relationship from MYGN g…

Castle Biosciences, Inc. Customers

TickerNameConfidenceEvidence
MEDICARE MEDICARE 90% Our revenue from patients covered by Medicare as a percentage of total revenue, was 47 % for the year ended December 31, 2024.
COMMERCIAL-PAYOR COMMERCIAL-PAYOR 85% Additionally, there was a commercial payor from which 15 % of our revenue from patients was derived for the year ended December 31, 2024.

Castle Biosciences, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
CSTL-DEBT Debt stack $10.1M 90% Market cache reports total debt of $10.1M.
CSTL-DEBT-8893 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.
CSTL-DEBT-8892 Warrants outstanding: 403142 90% xbrl warrant detail from xbrl 2020-12-31.

Castle Biosciences, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Castle Biosciences, Inc..

Castle Biosciences, Inc. Ownership

HolderNameConfidenceEvidence
CSTL-OWNER-BLACKROCK-INC BlackRock, Inc. 90% 13F overlay lists BlackRock, Inc. as top holder; 190 tracked holders.

Castle Biosciences, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
MYGN Myriad Genetics, Inc. 100.00 1 ['supplier']
BIOA BioAge Labs, Inc. 50.00 2
FLGT Fulgent Genetics, Inc. 50.00 2
DSGN Design Therapeutics, Inc. 50.00 2
BNTC Benitec Biopharma Inc. 50.00 2
CALC CalciMedica, Inc. 50.00 2
ALLO Allogene Therapeutics, Inc. 50.00 2
CTMX CytomX Therapeutics, Inc. 50.00 2
CABA Cabaletta Bio, Inc. 50.00 2
SDGR Schrödinger, Inc. 50.00 2
BCDA BioCardia, Inc. 50.00 2
ELVN Enliven Therapeutics, Inc. 50.00 2
ATYR aTyr Pharma, Inc. 50.00 2
BIAF bioAffinity Technologies, Inc. 50.00 2
BNR Burning Rock Biotech Limited 50.00 2
IMNM Immunome, Inc. 50.00 2
PSNL Personalis, Inc. 50.00 2
HOWL Werewolf Therapeutics, Inc. 50.00 2
GH Guardant Health, Inc. 50.00 2
BNBX BNB Plus Corp. 50.00 2
🔐
CSTL
Unlock CSTL Supply Chain Data
Verified relationships include:
SCIBASESCIBASESupplier90%
NORIDIAN-HEALTHCARE-SOLUTIONS-LLCNORIDIAN-HEALTHCARE-SOLUT…Supplier80%
MEDICAREMEDICARECustomer90%
COMMERCIAL-PAYORCOMMERCIAL-PAYORCustomer85%
+5 more relationships locked
Subscribe, View plans →